Introduction
============

Ankylosing spondylitis (AS) represents an increasingly frequent disease that can lead to significant damage to the respiratory system in advanced stages \[[@B1] \]. Thus, the effort capacity will diminish and the life comfort of the patients will be altered. Is a progressive systemic rheumatic disease, characterized by the inflammation of the sacroiliac joints, joints of the spine and occasionally large peripheral joints \[[@B1] , [@B2] \].

It evolves in four stages -- sacroiliac, lumbar, dorsal and cervical -- while occurrence of complications and extra-articular impairment is fairly common in the advanced stages of the disease \[[@B1] \].

In stage III (dorsal or thoracic) patients have chest and thoracico-abdominal pain as well as a limitation of the thorax expansion due to costovertebral and sternocostal joint damage during the inflammatory process. This difficulty in breathing progressively accentuates due to the restrictive ventilatory dysfunction produced by chest stiffness \[[@B1] ,[@B2] ,[@B3] ,[@B4] \]

Purpose of the study
====================

The evaluation of the ventilation function improval in patients with ankylosing spondylitis following the medical recovery procedures.

Patients and methods
====================

The study included 24 patients that were diagnosed with AS stages I and IV, with lumbo-sacral initial setting. The modified New York criteria (1984) were used for the inclusion.

Patients that had an evolution outburst of the disease were not included and neither did the ones with cardiac insufficiency phenomena, pectoral angina or coronary ischemia of any other kind, patients with fever and also the ones with chronic bronchopneumonia, tuberculosis, severe psychic diseases or lack of cooperation.

They were monitored for 24 months, according to the following parameters: ventilation functional tests, respiratory gas levels, thorax involvement in inspiration and expiration, the medical, physical and balneotherapy that they had followed. The age of the disease has started was also considered.

The activity of the disease was evaluated using the BASDAI score. The evaluation of the functional disability was based on the BASFI score and the life quality needed a dedicated 10-items/points questionnaire.

Gasometry and functional ventilation tests were applied to all patients at the beginning of the study and every 6 months. All patients had medical therapy with non-steroid anti-inflammatory drugs and physical therapy while being in the hospital and also at home with the exercise program for maintaining the mobility of the spine and for respiratory recovery.

We interpreted the data by using descriptive statistics and the Mann Whitney and Wilcoxon non-parametric tests for analyzing differences between means. Continuous data was expressed as mean and standard deviation (SD) All calculations were performed in GraphPad Prism 6 Demo (GraphPad Software Inc., USA).

Results
=======

The study included 24 patients, 22 men and two women (11/1 men/female ratio, Fig.[1](#F1){ref-type="fig"}), aged between 35 and 55 years. The disease debuted at a mean of 18 years (SD=2 years) before inclusion. We found a significant difference between the time disease started and the age of patients at inclusion (Mann-Whitney test, p\< 0.0001, tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and Fig. [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"})

After 24 months a significant improval was noticed concerning the restrictive ventilation dysfunction specific parameters and also an increase of oxygen pressure by a mean 7 mmHg (SD=2 mmHg). The Mann-Whitney test revealed a strong correlation between successful treatment and an increase oxygen pressure (p\<0.0001, tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and Fig. [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}).

We have found significant improvement of respiration motions after physical treatment; thorax involvement was greatly reduced in all patients after 24 months of rehabilitation techniques.

We have found a notable improvement in BASDAI, BASFI and Quality of Life scores after 24 months of treatment (Wilcoxon test, p\<0.0001). The results are presented in tables [4](#T4){ref-type="table"},[5](#T5){ref-type="table"},[6](#T6){ref-type="table"},[7](#T7){ref-type="table"},[8](#T8){ref-type="table"},[9](#T9){ref-type="table"},[10](#T10){ref-type="table"}. Mean scores were significantly different (Fig. [6](#F6){ref-type="fig"},[7](#F7){ref-type="fig"},[8](#F8){ref-type="fig"},[9](#F9){ref-type="fig"},[10](#F10){ref-type="fig"},[11](#F11){ref-type="fig"}).

![Male to female ratio in the studied lot.](CHSJ-41-04-406-fig1){#F1}

![Comparison of patient age versus age of disease onset.](CHSJ-41-04-406-fig2){#F2}

![Mean age of inclusion versus mean age of disease onset.](CHSJ-41-04-406-fig3){#F3}

![Variation of oxygen concentrations before and after physical treatment.](CHSJ-41-04-406-fig4){#F4}

![Mean oxygen concentrations before and after physical treatment.](CHSJ-41-04-406-fig5){#F5}

![BASDAI score values before and after physical treatment (lower values are better).](CHSJ-41-04-406-fig6){#F6}

![Mean BASDAI score values before and after physical treatment (lower values are better).](CHSJ-41-04-406-fig7){#F7}

![BASFI score values before and after physical treatment (lower values are better).](CHSJ-41-04-406-fig8){#F8}

![Mean BASFI score values before and after physical treatment (lower values are better).](CHSJ-41-04-406-fig9){#F9}

![Quality of Life (QoL) score values before and after physical treatment (higher values are better).](CHSJ-41-04-406-fig10){#F10}

![Mean Quality of Life (QoL) score values before and after physical treatment (higher values are better).](CHSJ-41-04-406-fig11){#F11}

###### 

Descriptive statistics presenting the data for age-related measurements within the patient lot.

  -------------------- ----------------------------- ----------------------
                       Age of patient at inclusion   Age of disease onset
  Number of values     24                            24
                                                     
  Minimum              35.00                         17.00
  25% Percentile       41.25                         23.25
  Median               46.50                         28.00
  75% Percentile       51.75                         33.75
  Maximum              55.00                         37.00
                                                     
  Mean                 46.21                         28.04
  Std. Deviation       6.276                         5.653
  Std. Error of Mean   1.281                         1.154
                                                     
  Lower 95% CI         43.56                         25.65
  Upper 95% CI         48.86                         30.43
                                                     
  Mean ranks           36.33                         12.67
  -------------------- ----------------------------- ----------------------

###### 

Mann-Whitney test showed significant differences between mean age of onset and age of inclusion in the study.

  ------------------------------------------------------ ---------------
  Age of disease onset vs. Age of patient at inclusion   
                                                         
  Mann Whitney test                                      
  P value                                                \< 0.0001
  Exact or approximate P value?                          Exact
  P value summary                                        \*\*\*\*
  Significantly different? (P \< 0.05)                   Yes
  One- or two-tailed P value?                            Two-tailed
  Sum of ranks in column A,B                             872.0 , 304.0
  Mann-Whitney U                                         4.000
                                                         
  Difference between medians                             
  Median of column A                                     46.50
  Median of column B                                     28.00
  Difference: Actual                                     -18.50
  Difference: Hodges-Lehmann                             -18.00
  ------------------------------------------------------ ---------------

###### 

Descriptive statistics presenting the data for oxygen pressure, pre and post treatment, within the patient lot.

  -------------------- --------------------- --------------------
                       O2 before treatment   O2 after treatment
  Number of values     24                    24
                                             
  Minimum              97.00                 90.00
  25% Percentile       97.25                 91.00
  Median               98.00                 92.00
  75% Percentile       99.00                 93.00
  Maximum              100.0                 94.00
                                             
  Mean                 98.38                 91.83
  Std. Deviation       1.056                 1.404
  Std. Error of Mean   0.2155                0.2866
                                             
  Lower 95% CI         97.93                 91.24
  Upper 95% CI         98.82                 92.43
                                             
  Mean ranks           36.50                 12.50
  -------------------- --------------------- --------------------

###### 

The Mann-Whitney test showed significant differences between mean oxygen pressure values before and after physical rehabilitation.

  ------------------------------------------- ---------------
  O2 after treatment vs.O2 before treatment   
                                              
  Mann Whitney test                           
  P value                                     \< 0.0001
  Exact or approximate P value?               Exact
  P value summary                             \*\*\*\*
  Significantly different? (P \< 0.05)        Yes
  One- or two-tailed P value?                 Two-tailed
  Sum of ranks in column A,B                  876.0 , 300.0
  Mann-Whitney U                              0.0
                                              
  Difference between medians                  
  Median of column A                          98.00
  Median of column B                          92.00
  Difference: Actual                          -6.000
  Difference: Hodges-Lehmann                  -7.000
  ------------------------------------------- ---------------

###### 

Descriptive statistics presenting the data for BASDAI test scores, pre and post treatment, within the patient lot.

  -------------------- --------------- -------------- ------------
                       BASDAI before   BASDAI after   Difference
  Minimum              5.000           2.000          -5.000
  25% Percentile       6.000           3.000          -4.000
  Median               7.000           4.000          -3.000
  75% Percentile       8.000           4.750          -3.000
  Maximum              9.000           5.000          -1.000
                                                      
  Mean                 7.000           3.792          -3.208
  Std. Deviation       1.103           0.8836         1.062
  Std. Error of Mean   0.2252          0.1804         0.2169
                                                      
  Lower 95% CI         6.534           3.419          -3.657
  Upper 95% CI         7.466           4.165          -2.760
  -------------------- --------------- -------------- ------------

###### 

The Wilcoxon test showed significant differences between mean BASDAI test scores before and after physical rehabilitation.

  ---------------------------------------------------- --------------
  BASDAI after treatment vs. BASDAI before treatment   
  P value                                              \< 0.0001
  Exact or approximate P value?                        Exact
  P value summary                                      \*\*\*\*
  Significantly different? (P \< 0.05)                 Yes
  One- or two-tailed P value?                          Two-tailed
  Sum of positive, negative ranks                      0.0 , -300.0
  Sum of signed ranks (W)                              -300.0
                                                       
  Median of differences                                
  Median                                               -3.000
                                                       
  ---------------------------------------------------- --------------

###### 

Descriptive statistics presenting the data for BASFI test scores, pre and post treatment

  -------------------- -------------- ------------- ------------
                       BASFI before   BASFI after   Difference
  Minimum              5.000          2.000         -5.000
  25% Percentile       6.000          3.000         -4.000
  Median               7.000          4.000         -3.000
  75% Percentile       8.000          4.000         -3.000
  Maximum              9.000          6.000         -2.000
                                                    
  Mean                 6.875          3.625         -3.250
  Std. Deviation       0.9918         0.9696        0.8470
  Std. Error of Mean   0.2025         0.1979        0.1729
                                                    
  Lower 95% CI         6.456          3.216         -3.608
  Upper 95% CI         7.294          4.034         -2.892
  -------------------- -------------- ------------- ------------

###### 

The Wilcoxon test showed significant differences between mean BASFI test scores before and after physical rehabilitation.

  -------------------------------------------------- --------------
  BASFI after treatment vs. BASFI before treatment   
  P value                                            \< 0.0001
  Exact or approximate P value?                      Exact
  P value summary                                    \*\*\*\*
  Significantly different? (P \< 0.05)               Yes
  One- or two-tailed P value?                        Two-tailed
  Sum of positive, negative ranks                    0.0 , -300.0
  Sum of signed ranks (W)                            -300.0
                                                     
  Median of differences                              
  Median                                             -3.000
                                                     
  -------------------------------------------------- --------------

###### 

Descriptive statistics presenting the data for QoL test scores, pre and post treatment

  -------------------- ------------ ----------- ------------
                       QoL before   QoL after   Difference
  Number of values     24           24          24
                                                
  Minimum              4.000        7.000       1.000
  25% Percentile       6.000        8.000       2.000
  Median               6.000        9.000       2.000
  75% Percentile       7.000        9.000       2.750
  Maximum              8.000        9.000       4.000
                                                
  Mean                 6.333        8.500       2.167
  Std. Deviation       1.090        0.6594      0.7020
  Std. Error of Mean   0.2225       0.1346      0.1433
                                                
  Lower 95% CI         5.873        8.222       1.870
  Upper 95% CI         6.794        8.778       2.463
  -------------------- ------------ ----------- ------------

###### 

The Wilcoxon test showed significant differences between mean QoL test scores before and after physical rehabilitation.

  ---------------------------------------------- -------------
  QoL after treatment vs. QoL before treatment   
  P value                                        \< 0.0001
  Exact or approximate P value?                  Exact
  P value summary                                \*\*\*\*
  Significantly different? (P \< 0.05)           Yes
  One- or two-tailed P value?                    Two-tailed
  Sum of positive, negative ranks                300.0 , 0.0
  Sum of signed ranks (W)                        300.0
                                                 
  Median of differences                          
  Median                                         2.000
                                                 
  ---------------------------------------------- -------------

Discussion
==========

Recovery procedures for chest mobility are essential in improving prognosis and comfort of life of patients with AS \[[@B5] ,[@B6] ,[@B7] ,[@B8] ,[@B9]\].

Passive and active-passive mobilization of the head and shoulders, the arms and hands, are executed after a well-established program and are repeated 2-3 times a day. Upper limbs should stay in semi-abduction. Massage of the neck, shoulders and chest is also advised.

Considering that almost all patients with stages III and IV AS have abdominal breathing (due to costovertebral and sterno-costal joint damage during the inflammatory process) it is absolutely necessary to retrain the diaphragm and abdominal wall muscles in the respiratory process \[[@B5] , [@B6]\].

Respiratory gymnastics must selectively act on each respiratory phase, following four objectives \[[@B1] , [@B3] , [@B8] ,[@B9] ,[@B10]\]:

\- Increasing the mobilized air volumes for the entire lung

\- Coordination of the respiratory rate

\- Toning respiratory muscles

\- Decrease ventilatory labor

The most disturbing symptom for a respiratory patient is the lower effort capacity expressed by dyspnea of different degrees. Administering O2 to correct hypoxemia is very important for increasing ventilation efficiency and the available energy of the inspiratory muscles \[[@B1] , [@B2] , [@B6]\].

Increasing the efficiency of the respiratory muscles can be achieved by improving muscle metabolic capacity to faster extract energy sources from the blood and use them as well as possible. Like with any muscle, this metabolic capacity increases as the muscle is trained by physical effort \[[@B2] ,[@B5] ,[@B6] ,[@B7]\].

Muscle training should be performed in general physical rest to reduce peripheral metabolic needs and to obtain a preferential distribution infusion to peripheral musculature.

In the methodology for functional recovery of respiratory deficiencies, physiotherapy represents one of the main procedures. It is applied during hospital admissions; however, it is imperative that patients continue their daily exercises at home, to maintain mobility of the ribcage and consequently of the respiratory muscles \[[@B2] , [@B10]\].

The main issue that we focused on in our patients were:

\- Relaxation techniques

\- Posture (items facilitating breathing and bronchial drainage)

\- Corrective gymnastics

\- Respiratory Reeducation

\- Dosed effort training.

We found several parameters that improved after correct physical rehabilitation techniques. This is in accord with recent studies \[[@B3] \], as well as classical literature \[[@B5] ,[@B6] ,[@B7]\]. Patients with rheumatic disease experience rapid and important improvement of the quality of life, thus extending life expectancy and reduce co-morbidity.

This is a preliminary study on a limited number of patients, this being the main drawback of this research; future studies in the form of large scale multi-center trials, preferably with randomized candidates, should be performed to determine the exact extent to which physical rehabilitation can aid AS patients, with high implications for therapy and management.

Conclusions
===========

The constant and correct application of the respiration recovery and the spine mobility procedures lead to better life quality regarding the patients with AS and the main parameters that evaluate ventilation dysfunction: oxygen pressure and residual volume, vital capacity, maximal expiratory volume, inspiratory reserve volume, expiratory reserve volume, total pulmonary capacity.
